Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Protection provided by vaccination, booster doses and previous infection against covid-19 infection, hospitalisation or death over time in Czechia

L. Berec, M. Šmíd, L. Přibylová, O. Májek, T. Pavlík, J. Jarkovský, M. Zajíček, J. Weiner, T. Barusová, J. Trnka

. 2022 ; 17 (7) : e0270801. [pub] 20220708

Language English Country United States

Document type Journal Article

Studies demonstrating the waning of post-vaccination and post-infection immunity against covid-19 generally analyzed a limited range of vaccines or subsets of populations. Using Czech national health data from the beginning of the covid-19 pandemic till November 20, 2021 we estimated the risks of reinfection, breakthrough infection, hospitalization and death by a Cox regression adjusted for sex, age, vaccine type and vaccination status. Vaccine effectiveness against infection declined from 87% at 0-2 months after the second dose to 53% at 7-8 months for BNT162b2 vaccine, from 90% at 0-2 months to 65% at 7-8 months for mRNA-1273, and from 83% at 0-2 months to 55% at 5-6 months for the ChAdOx1-S. Effectiveness against hospitalization and deaths declined by about 15% and 10%, respectively, during the first 6-8 months. Boosters (third dose) returned the protection to the levels observed shortly after dose 2. In unvaccinated, previously infected individuals the protection against infection declined from 97% after 2 months to 72% at 18 months. Our results confirm the waning of vaccination-induced immunity against infection and a smaller decline in the protection against hospitalization and death. Boosting restores the original vaccine effectiveness. Post-infection immunity also decreases over time.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22025253
003      
CZ-PrNML
005      
20240117121204.0
007      
ta
008      
221017s2022 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1371/journal.pone.0270801 $2 doi
035    __
$a (PubMed)35802590
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Berec, Luděk $u Centre for Mathematical Biology, Institute of Mathematics, Faculty of Science, University of South Bohemia, České Budějovice, Czech Republic $u Department of Ecology, Czech Academy of Sciences, Biology Centre, Institute of Entomology, České Budějovice, Czech Republic $u Centre for Modelling of Biological and Social Processes, Praha, Czech Republic $1 https://orcid.org/0000000224193324
245    10
$a Protection provided by vaccination, booster doses and previous infection against covid-19 infection, hospitalisation or death over time in Czechia / $c L. Berec, M. Šmíd, L. Přibylová, O. Májek, T. Pavlík, J. Jarkovský, M. Zajíček, J. Weiner, T. Barusová, J. Trnka
520    9_
$a Studies demonstrating the waning of post-vaccination and post-infection immunity against covid-19 generally analyzed a limited range of vaccines or subsets of populations. Using Czech national health data from the beginning of the covid-19 pandemic till November 20, 2021 we estimated the risks of reinfection, breakthrough infection, hospitalization and death by a Cox regression adjusted for sex, age, vaccine type and vaccination status. Vaccine effectiveness against infection declined from 87% at 0-2 months after the second dose to 53% at 7-8 months for BNT162b2 vaccine, from 90% at 0-2 months to 65% at 7-8 months for mRNA-1273, and from 83% at 0-2 months to 55% at 5-6 months for the ChAdOx1-S. Effectiveness against hospitalization and deaths declined by about 15% and 10%, respectively, during the first 6-8 months. Boosters (third dose) returned the protection to the levels observed shortly after dose 2. In unvaccinated, previously infected individuals the protection against infection declined from 97% after 2 months to 72% at 18 months. Our results confirm the waning of vaccination-induced immunity against infection and a smaller decline in the protection against hospitalization and death. Boosting restores the original vaccine effectiveness. Post-infection immunity also decreases over time.
650    _2
$a vakcína BNT162 $7 D000090982
650    12
$a COVID-19 $x prevence a kontrola $7 D000086382
650    _2
$a hospitalizace $7 D006760
650    _2
$a lidé $7 D006801
650    _2
$a pandemie $7 D058873
650    _2
$a vakcinace $7 D014611
651    _2
$a Česká republika $x epidemiologie $7 D018153
655    _2
$a časopisecké články $7 D016428
700    1_
$a Šmíd, Martin $u Centre for Modelling of Biological and Social Processes, Praha, Czech Republic $u Czech Academy of Sciences, Institute of Information Theory and Automation, Praha, Czech Republic
700    1_
$a Přibylová, Lenka $u Department of Mathematics and Statistics, Faculty of Science, Masaryk University, Brno, Czech Republic
700    1_
$a Májek, Ondřej $u Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic $u Institute of Health Information and Statistics of the Czech Republic, Praha, Czech Republic $1 https://orcid.org/0000000200343084
700    1_
$a Pavlík, Tomáš $u Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic $u Institute of Health Information and Statistics of the Czech Republic, Praha, Czech Republic
700    1_
$a Jarkovský, Jiří $u Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic $u Institute of Health Information and Statistics of the Czech Republic, Praha, Czech Republic
700    1_
$a Zajíček, Milan, $u Czech Academy of Sciences, Institute of Information Theory and Automation, Praha, Czech Republic $d 1971- $7 ntka174464
700    1_
$a Weiner, Jakub $u Centre for Modelling of Biological and Social Processes, Praha, Czech Republic $u Siesta Labs, Praha, Czech Republic
700    1_
$a Barusová, Tamara $u First Faculty of Medicine, Charles University, Praha, Czech Republic $u Department of Statistical Modelling, Czech Academy of Sciences, Institute of Computer Science, Praha, Czech Republic $7 xx0312819
700    1_
$a Trnka, Jan $u Department of Biochemistry, Cell and Molecular Praha, Czech Republic
773    0_
$w MED00180950 $t PloS one $x 1932-6203 $g Roč. 17, č. 7 (2022), s. e0270801
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35802590 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20221017 $b ABA008
991    __
$a 20240117121200 $b ABA008
999    __
$a ok $b bmc $g 1854782 $s 1176543
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 17 $c 7 $d e0270801 $e 20220708 $i 1932-6203 $m PLoS One $n PLoS One $x MED00180950
LZP    __
$a Pubmed-20221017

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...